Windtree Therapeutics Inc (WINT)

[DueDiligenceMax]

Looking for a (Healthcare) NASDAQ stock whose run has just BEGUN??? Well, WINT may be the one:

https://www.investorsobserver.com/news/stock-update/healthcare-stocks-moving-friday-sens-wint-cgem-eyes-harp-ppbt-slrx-clrb
"Windtree Therapeutics Inc (WINT) stock is trading at $2.90, a rise of $0.92, or 37.85%, on high volume. Windtree Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.75."
/////////////////////////////////////////////////////
https://markets.financialcontent.com/stocks/news/read/41430807/meme_penny_stocks
"One of the largest gainers of the day so far is WINT stock, pushing up by over 55% by midday on June 4th. The main reason for this gain is that the analyst group Oppenheimer covered the stock, and put both an Outperform rating as well as an $8 price target on it. Price targets are not usually a be-all-end-all factor, but they do tend to make a stock move in either direction.
"And, analysts usually know what they’re talking about, which means that these targets are worth paying attention to. But, investors should also do their research into a company before deciding to pull the trigger. Windtree Therapeutics Inc. is a biotech company, developing KL4 aerosolized surfactant therapies. These can be used in respiratory diseases. Additionally, its AEROSURF proprietary technology platform is in development for the treatment of respiratory distress syndrome in infants."